| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 2-Yr Return |
|---|---|---|---|---|---|
|
GILD
Gilead Sciences
|
Jul 09, 2026 | BUY |
Strong Buy
-8.3% avg upside
66 analysts
|
$160.00
23.16% Upside
|
-3.7% |
|
ABBV
AbbVie
|
Jul 09, 2026 | BUY |
Strong Buy
-6.7% avg upside
46 analysts
|
$280.00
12.77% Upside
|
-0.7% |
|
PFE
Pfizer
|
Jul 08, 2026 | HOLD |
Buy
+39.2% avg upside
45 analysts
|
$28.00
15.86% Upside
|
+0.5% |
|
JNJ
Johnson & Johnson
|
Jul 07, 2026 | HOLD |
Strong Buy
-14.0% avg upside
36 analysts
|
$260.00
1.26% Upside
|
-3.8% |
|
LLY
Eli Lilly & Co
|
Jul 07, 2026 | BUY |
Strong Buy
-13.6% avg upside
47 analysts
|
$1400.00
17.85% Upside
|
-3.8% |
|
TEVA
Teva Pharmaceutical
|
Jun 15, 2026 | BUY |
Buy
-10.8% avg upside
39 analysts
|
— | -2.2% |
|
REGN
Regeneron
|
May 18, 2026 | BUY |
Strong Buy
+16.2% avg upside
58 analysts
|
$850.00
27.93% Upside
|
+5.7% |
|
ZTS
Zoetis
|
May 08, 2026 | BUY |
Buy
+67.5% avg upside
22 analysts
|
$130.00
72.14% Upside
|
-8.8% |
|
VTRS
Viatris
|
May 08, 2026 | HOLD |
Buy
+41.8% avg upside
21 analysts
|
$18.00
10.63% Upside
|
-4.5% |
|
RPRX
Royalty Pharma
|
May 07, 2026 | BUY |
Strong Buy
-3.5% avg upside
15 analysts
|
$58.00
2.68% Upside
|
+12.7% |
|
ELAN
Elanco Animal Health
|
May 07, 2026 | BUY |
Strong Buy
+22.6% avg upside
18 analysts
|
$30.00
20.80% Upside
|
+2.7% |
|
BIIB
Biogen
|
Apr 24, 2026 | HOLD |
Strong Buy
+24.2% avg upside
52 analysts
|
$185.00
7.19% Downside
|
+8.0% |
|
MRK
Merck & Company
|
Apr 06, 2026 | BUY |
Strong Buy
+4.0% avg upside
43 analysts
|
$135.00
9.36% Upside
|
+3.0% |
|
AMRX
Amneal Pharmaceuticals
|
Mar 02, 2026 | BUY |
Strong Buy
+1.1% avg upside
18 analysts
|
$18.00
5.86% Upside
|
+23.2% |
|
PRGO
Perrigo Company
|
Feb 27, 2026 | HOLD |
Buy
+567.5% avg upside
20 analysts
|
$15.00
46.74% Upside
|
-16.5% |
|
OGN
Organon
|
Feb 13, 2026 | SELL |
Sell
+9.9% avg upside
9 analysts
|
$11.00
18.59% Downside
|
-83.0% |
|
BMY
Bristol-Myers Squibb
|
Jan 28, 2026 | BUY |
Buy
+2.3% avg upside
42 analysts
|
$65.00
12.97% Upside
|
+7.7% |
|
IDXX
Idexx Laboratories
|
Nov 03, 2025 | BUY |
Buy
+28.9% avg upside
17 analysts
|
$775.00
37.55% Upside
|
-22.0% |
|
AMGN
Amgen
|
Sep 16, 2025 | HOLD |
Buy
-17.8% avg upside
57 analysts
|
$300.00
17.43% Downside
|
+36.0% |
|
CHRS
Coherus Biosciences
|
May 25, 2023 | HOLD |
Buy
+715.2% avg upside
18 analysts
|
$8.00
419.42% Upside
|
-82.4% |
|
TSE:BHC
Bausch Health Companies
|
Jul 28, 2022 | HOLD |
Buy
+784.6% avg upside
29 analysts
|
— | · |
|
TXMD
TherapeuticsMD
|
May 19, 2020 | HOLD |
Buy
+212.5% avg upside
8 analysts
|
— | -95.9% |
|
DE:MRK
Merck KGaA
|
Mar 09, 2020 | BUY |
Buy
-2.8% avg upside
33 analysts
|
$85.83
38.66% Downside
|
· |
|
PCRX
Pacira Pharmaceuticals
|
Feb 20, 2020 | HOLD |
Buy
+52.8% avg upside
21 analysts
|
$54.00
111.98% Upside
|
+27.8% |
|
SNNAQ
Sienna Biopharmaceuticals
|
May 13, 2019 | HOLD |
Buy
+299999899.9% avg upside
2 analysts
|
— | -33.3% |
|
KALA
KALA BIO
|
Nov 17, 2017 | BUY |
Strong Buy
+18039.8% avg upside
9 analysts
|
$35.00
2878.64% Upside
|
-80.3% |
|
AMRN
Amarin
|
Oct 17, 2013 | HOLD |
Hold
-43.2% avg upside
18 analysts
|
— | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.